Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
Wolfe
M M
MM
Section of Gastroenterology, Boston University School of Medicine and Boston Medical Center, MA 02118-2393, USA. michael.wolfe@bmc.org
Lichtenstein
D R
DR
Singh
G
G
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000145:classification / Q000494:pharmacology; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004415:Dyspepsia / Q000139:chemically induced / Q000188:drug therapy; D005753:Gastric Mucosa / Q000187:drug effects; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000401:mortality; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects; D010437:Peptic Ulcer / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D011453:Prostaglandins / Q000502:physiology; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D011453:Prostaglandins